Stockreport
Incyte: Why The Market Is Overreacting To A Guidance 'Miss' [Seeking Alpha]
Last incyte corporation earnings: 2/13 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations: incyte.com/ir/investor-overview.aspx
Adjusted for royalties, INCY's 2026 sales guidance is nearly in line with expectations, representing 11.5% YoY growth in Net Product Sales. Opzelura sales guidance was slightly below consensus, but the ex-Jakafi portfolio is growing rapidly, supporting a robust long-term outlook. I reiterate my Strong Buy rating with a $131/share price target, viewing the recent sell-off as a contrarian buying opportunity. JHVEPhoto/iStock Editorial via Getty Images Incyte ( INCY ) delivered Q4 earnings results yesterday that were mixed, with non-GAAP EPS coming in short of expectations even as revenue exceeded them. However, the number that moved the market was 2026 guidance. Management guided to This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of INCY either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeki
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | INCY | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
INCY alerts
INCY alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
INCY alerts
High impacting Incyte Corporation news events
Weekly update
A roundup of the hottest topics
INCY
NEWS
NEWS
- Incyte (NASDAQ:INCY) had its price target lowered by analysts at Royal Bank Of Canada from $95.00 to $92.00. They now have a "sector perform" rating on the stock.[MarketBeat]
- Incyte (NASDAQ:INCY) was given a new $102.00 price target on by analysts at Morgan Stanley.[MarketBeat]
- Incyte (NASDAQ:INCY) had its price target lowered by analysts at Wells Fargo & Company from $107.00 to $101.00. They now have an "equal weight" rating on the stock.[MarketBeat]
- Incyte (NASDAQ:INCY) was given a new $120.00 price target on by analysts at Stifel Nicolaus.[MarketBeat]
- Incyte (NASDAQ:INCY) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $135.00 price target on the stock.[MarketBeat]
- More
INCY
SEC Filings
SEC Filings
- 2/10/26 - Form SCHEDULE
- 2/10/26 - Form 10-K
- 2/10/26 - Form 8-K
- INCY's page on the SEC website
- More